Search

Your search keyword '"Apolipoprotein B-48"' showing total 1,156 results

Search Constraints

Start Over You searched for: Descriptor "Apolipoprotein B-48" Remove constraint Descriptor: "Apolipoprotein B-48"
1,156 results on '"Apolipoprotein B-48"'

Search Results

1. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.

2. Lipin 2/3 phosphatidic acid phosphatases maintain phospholipid homeostasis to regulate chylomicron synthesis

3. Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

4. The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

5. Diagnostic Potential of Autophagy-5 Protein, Apolipoprotein B-48, and Oxidative Stress Markers in Serum of Patients with Early-Stage Ischemic Stroke.

6. Apolipoprotein B-48 and late graft failure in kidney transplant recipients.

7. Study Findings from University Medical Center Groningen Update Knowledge in Kidney Transplants (Apolipoprotein B-48 and late graft failure in kidney transplant recipients).

8. Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance

9. Study Findings on Hypobetalipoproteinemias Are Outlined in Reports from Oslo University Hospital (Missense Mutation Q384k In the Apob Gene Affecting the Large Lipid Transfer Module of Apob Reduces the Secretion of Apob-100 In the Liver Without...).

10. Postprandial dyslipidemia in insulin resistant states in adolescent populations.

11. Diagnostic Potential of Autophagy-5 Protein, Apolipoprotein B-48, and Oxidative Stress Markers in Serum of Patients with Early-Stage Ischemic Stroke

12. Enteral glucose, absorbed and metabolized, potently enhances mesenteric lymph flow in chow- and high-fat-fed rats

14. The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels

15. Intestinal lipid absorption and transport in type 2 diabetes

16. Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis

18. Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome

19. The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia

20. Insights from human congenital disorders of intestinal lipid metabolism

21. Apo B-48 gene expression and low-density lipoprotein as a factor for increased insulin resistance and severity of acne.

22. Unanticipated Enhancement of Intestinal TG Output by Apoc3 ASO Inhibition.

23. Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine.

24. Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan

25. Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations

26. ROL DEL ENTEROCITO EN LA DISLIPIDEMIA DE LA DIABETES MELLITUS TIPO 2.

27. Differential impact of the cheese matrix on the postprandial lipid response: a randomized, crossover, controlled trial.

28. Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study

29. Pitie-Salpetriere Hospital Researcher Discusses Research in Short Bowel Syndrome (Circulating Apolipoprotein B-48 as a Biomarker of Parenteral Nutrition Dependence in Adult Patients with Short Bowel Syndrome).

30. Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials

31. Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism

32. Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance

33. Feeding activates FGF15-SHP-TFEB-mediated lipophagy in the gut

34. Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein

35. The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels.

36. C-reactive protein levels are inversely correlated with the apolipoprotein B-48-containing triglyceride-rich lipoprotein production rate in insulin resistant men.

37. Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity

38. ApoB48-remnant lipoproteins are associated with increased cardiometabolic risk in adolescents

39. Acute whole apple consumption did not influence postprandial lipaemia: a randomised crossover trial

40. Associations between insulin-like growth factor binding protein-2 and lipoprotein kinetics in men

41. Impact of Sequential Lipid Meals on Lymphatic Lipid Absorption and Transport in Rats

42. Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia

43. Chylomicron remnants are increased in the postprandial state in CD36 deficiency

44. Matrix structure of dairy products results in different postprandial lipid responses::a randomized crossover trial

45. Recent dynamic studies of the metabolism of atherogenic lipoproteins: elucidating the mode of action of new therapies

46. A bibliometric analysis and visualization of literature on non-fasting lipid research from 2012 to 2022.

48. Diagnostic Value of ATG5, Apo-Lipoprotein B-48, Thyroid Hormones, and Homocysteine in Patients with Alzheimer's Disease.

49. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat

50. Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome.

Catalog

Books, media, physical & digital resources